BEAM
Price
$26.87
Change
+$1.45 (+5.70%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
2.57B
25 days until earnings call
Intraday Buy/Sell Signals
LCTX
Price
$1.79
Change
+$0.02 (+1.13%)
Updated
Oct 14 closing price
Capitalization
408.76M
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs LCTX

Header iconBEAM vs LCTX Comparison
Open Charts BEAM vs LCTXBanner chart's image
Beam Therapeutics
Price$26.87
Change+$1.45 (+5.70%)
Volume$3K
Capitalization2.57B
Lineage Cell Therapeutics
Price$1.79
Change+$0.02 (+1.13%)
Volume$1.39M
Capitalization408.76M
BEAM vs LCTX Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. LCTX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and LCTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (BEAM: $25.42 vs. LCTX: $1.79)
Brand notoriety: BEAM and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 75% vs. LCTX: 84%
Market capitalization -- BEAM: $2.57B vs. LCTX: $408.76M
BEAM [@Biotechnology] is valued at $2.57B. LCTX’s [@Biotechnology] market capitalization is $408.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than LCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while LCTX’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • LCTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +1.15% price change this week, while LCTX (@Biotechnology) price change was +3.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

LCTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.57B) has a higher market cap than LCTX($409M). LCTX YTD gains are higher at: 256.219 vs. BEAM (2.500). LCTX has higher annual earnings (EBITDA): -19.77M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. LCTX (42.3M). LCTX has less debt than BEAM: LCTX (2.15M) vs BEAM (155M). BEAM has higher revenues than LCTX: BEAM (60.3M) vs LCTX (10.9M).
BEAMLCTXBEAM / LCTX
Capitalization2.57B409M629%
EBITDA-414.33M-19.77M2,096%
Gain YTD2.500256.2191%
P/E RatioN/AN/A-
Revenue60.3M10.9M553%
Total Cash1.15B42.3M2,719%
Total Debt155M2.15M7,196%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
59
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMLCTX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 8 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 8 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 8 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 8 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 8 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 8 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 8 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIGWX17.090.11
+0.65%
Putnam International Value R6
WOOSX17.80N/A
N/A
JPMorgan SMID Cap Equity R6
ARZDX6.10N/A
N/A
AMG River Road Dividend All Cap Value Z
JVLCX24.06N/A
N/A
JHancock Disciplined Value C
PMJIX11.50N/A
N/A
PIMCO RAE US Small Instl

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.12%
CRSP - BEAM
66%
Closely correlated
+1.60%
NTLA - BEAM
63%
Loosely correlated
+0.57%
RXRX - BEAM
62%
Loosely correlated
+6.51%
AXON - BEAM
57%
Loosely correlated
-0.75%
PRME - BEAM
55%
Loosely correlated
+6.02%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with PYXS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+1.13%
PYXS - LCTX
35%
Loosely correlated
-6.38%
ELVN - LCTX
34%
Loosely correlated
-2.80%
NUVL - LCTX
34%
Loosely correlated
-5.67%
MGNX - LCTX
33%
Loosely correlated
-1.83%
BEAM - LCTX
33%
Poorly correlated
+0.12%
More